Kawasumi Laboratories Inc. announced consolidated earnings results for the nine months ended December 31, 2017. For the period, the company reported net sales of JPY 19,253 million, operating income of JPY 621 million, ordinary income of JPY 744 million, profit attributable to owners of the parent of JPY 492 million or net income per share of JPY 22.57 compared to net sales of JPY 18,404 million, operating income of JPY 802 million, ordinary income of JPY 916 million, net income of JPY 979 million or net income per share of JPY 44.90 for the same period last year. Profit before income taxes was JPY 690 million against JPY 937 million a year ago. Net cash provided by operating activities was JPY 1,864 million against JPY 1,805 million a year ago. Purchase of property, plant and equipment was JPY 504 million against JPY 850 million a year ago. Purchase of intangible assets was JPY 37 million against JPY 230 million a year ago.

For the full year of fiscal year ending March 31, 2018, the company expects consolidated net sales of JPY 25,000 million, operating income of JPY 600 million, ordinary income of JPY 650 million, profit attributable to owners of the parent of JPY 600 million or net income per share of JPY 27.50.

The company provided dividend guidance for the year end of fiscal year ending March 31, 2018. For the year, the company expects dividend of JPY 7.50 per share against JPY 10.00 per share a year ago.